Search for Clinical Trial Results

Sponsored By

Cardiomyopathy, Hypertrophic - 30 Studies Found

Status Study
Not yet recruiting Study Name: UTSW HP [13-C] Pyruvate Injection in HCM
Condition: Cardiomyopathy, Hypertrophic
Date: 2017-01-10
Interventions: Drug: Hyperpolarized 13C-Pyruvate All subjects will be observed for myocardial hyperpolarized [1-13C]pyr
Completed Study Name: Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study
Condition: Hypertrophic Cardiomyopathy
Date: 2002-05-02
Interventions: Procedure: trans-right ventricular alcohol septal ablation (TRVASA)
Completed Study Name: Biventricular Pacing in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Date: 2007-07-18
Interventions: Device: Biventricular Pacemaker
Completed Study Name: Trimetazidine Therapy in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Date: 2012-09-27
Interventions:
  • Drug: Trimetazidine Trimetazid
Completed Study Name: New Diagnostic Strategy in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Date: 2015-08-05
Interventions: Other: blood sample
Completed Study Name: Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease
Condition: Cardiomyopathy, Hypertrophic, Familial
Date: 1999-11-03
Completed Study Name: Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy
Condition: Familial Hypertrophic Cardiomyopathy
Date: 2013-02-07
Completed Study Name: Genetic Analysis of Familial Hypertrophic Cardiomyopathy
Condition:
  • Cardiovascular Diseases
  • Heart Diseases
  • Myocardial Diseases
    Date: 2000-05-25
NOT_YET_RECRUITING Study Name: A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Condition: Cardiomyopathy, Hypertrophic
Date: 2025-11-05
Interventions: Specified dose on specified days
Completed Study Name: A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Condition: Cardiomyopathy, Hypertrophic
Date: 2025-11-05
Interventions: Specified dose on specified days
<<< Previous